STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic

Xiaohong Wang1, Tao Chen1, Sizhe Chen1

  • 1State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, 250012, China.

Insights

Myocardial ischemia-reperfusion (MI/R) injury involves ferroptosis, a cell death pathway. The study identifies the STING-GPX4 axis, regulated by autophagy, as a key driver of ferroptosis, offering new therapeutic targets for heart disease.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Death Mechanisms

Background:

  • Myocardial ischemia-reperfusion (MI/R) injury remains a significant cause of mortality despite advancements in reperfusion therapies.
  • Understanding the molecular mechanisms of MI/R injury is critical for developing effective treatments to reduce cardiac damage and improve patient outcomes.

Purpose of the Study:

  • To elucidate the novel mechanisms underlying MI/R injury, focusing on the role of ferroptosis and its regulators.
  • To identify potential therapeutic targets for mitigating MI/R-induced myocardial damage.

Main Methods:

  • Investigated the double-stranded DNA (dsDNA)-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway in cardiomyocytes during MI/R.
  • Utilized genetic deletion of cGAS and STING in cardiomyocytes, assessed ferroptosis markers, and analyzed oxidative stress levels.
  • Examined the interaction between STING and glutathione peroxidase 4 (GPX4) using molecular assays and in vivo models.
  • Therapeutic interventions included adeno-associated virus (AAV)-mediated GPX4 administration and STING inhibition with H-151.

Main Results:

  • MI/R injury is associated with the accumulation of dsDNA-cGAS-STING signaling and increased myocardial ferroptosis.
  • Deletion of cGAS or STING in cardiomyocytes inhibited oxidative stress, mitigated ferroptosis, and reduced I/R injury.
  • STING directly promotes GPX4 degradation via autophagy, creating a positive feedback loop that drives ferroptosis.
  • Blocking the STING-GPX4 interaction or inhibiting STING stabilized GPX4, alleviated ferroptosis, and improved cardiac function post-MI/R.

Conclusions:

  • A novel autophagy-dependent ferroptosis mechanism is identified in MI/R injury, mediated by the STING-GPX4 axis.
  • STING-induced autophagy leads to GPX4 degradation during ischemia-reperfusion, contributing to cardiomyocyte death.
  • Targeting the STING-GPX4 interaction or STING itself represents a promising therapeutic strategy for heart diseases involving I/R injury.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.6K